Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Haemonetics

Haemonetics (NYSE: HAE) insider transactions

In the twelve months to 10 November 2026, executives and directors of Haemonetics reported no open-market sales and no open-market purchases, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Haemonetics shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
30 October 2026Galvin RoyEVP, Chief Commercial OfficerShares withheld for tax−146$119.6539,805Form 4
24 July 2026Abernathy Robert EDirectorGrant or award+2,538—27,519Form 4
24 July 2026Bryant Diane MDirectorGrant or award+2,538—9,664Form 4
24 July 2026Coyle Michael JDirectorGrant or award+2,538—17,932Form 4
24 July 2026Johnson Lloyd EmersonDirectorGrant or award+2,538—15,471Form 4
24 July 2026Kroll Mark WDirectorGrant or award+2,538—27,295Form 4
24 July 2026Pomeroy ClaireDirectorGrant or award+2,538—19,410Form 4
24 July 2026Zane Ellen MDirectorGrant or award+2,538—21,911Form 4
24 July 2026Madaus Martin DDirectorGrant or award+2,538—2,538Form 4
5 June 2026Miller Laurie A.SVP, Human ResourcesShares withheld for tax−313$71.2840,987Form 4
5 June 2026Maunsell Farris MaryanneVP, Chief Accounting OfficerShares withheld for tax−259$71.286,242Form 4
15 May 2026Simon, ChristopherPresident & CEOShares withheld for tax−9,681$56.29366,360Form 4
15 May 2026Simon, ChristopherPresident & CEOGrant or award+78,344—444,704Form 4
15 May 2026Miller Laurie A.SVP, Human ResourcesShares withheld for tax−948$56.2927,977Form 4
15 May 2026Miller Laurie A.SVP, Human ResourcesGrant or award+13,323—41,300Form 4
15 May 2026Galvin RoyEVP, Chief Commercial OfficerShares withheld for tax−879$56.2912,347Form 4
15 May 2026Galvin RoyEVP, Chief Commercial OfficerGrant or award+27,535—39,882Form 4
15 May 2026Maunsell Farris MaryanneVP, Chief Accounting OfficerShares withheld for tax−197$56.294,281Form 4
15 May 2026Maunsell Farris MaryanneVP, Chief Accounting OfficerGrant or award+2,220—6,501Form 4
15 May 2026DArecca JamesEVP, Chief Financial OfficerShares withheld for tax−2,505$56.2925,132Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Haemonetics page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.